Blog

The One Health Initiative

November 3, 2017

By Steven King, PhD, EVP, Sustainable Supply, Ethnobotanical Research & IP, Jaguar Health The One Health concept, at its most basic level, describes the interrelationship…

Read More

Treatment of Diarrhea & Dehydration in Dairy & Beef Calves

October 30, 2017

By Andre Teixeira, DVM, PhD, Veterinary Affairs Director, Jaguar Health Part 3 in a 3-part series on diarrhea and dehydration in dairy & beef calves The…

Read More

Pit Bull Awareness

October 28, 2017

By Niki Waldron, Head of Formulation Part of Jaguar’s staff contribution series To start off… “Pit Bull” is NOT a breed. It’s a term used…

Read More

Dog vs. Rattlesnake

October 20, 2017

By Niki Waldron, Head of Formulation Part of Jaguar’s staff contribution series The return of warm, sunny weather always pulls us outside, so on the…

Read More

Prevention of Diarrhea & Dehydration in Dairy & Beef Calves

October 10, 2017

By Andre Teixeira, DVM, PhD, Veterinary Affairs Director, Jaguar Health Part 2 in a 3-part series on diarrhea and dehydration in dairy & beef calves Calf…

Read More

Climate, Biodiversity & Indigenous Peoples

October 9, 2017

By Steven King, PhD, EVP, Sustainable Supply, Ethnobotanical Research & IP Indigenous Peoples Day is celebrated on the second Monday of October, and it is…

Read More

Second Lease on Life for Shelter Dogs

October 3, 2017

By Stephen Palmer, Clinical Trial Manager According to the American Society for the Prevention of Cruelty to Animals (ASPCA), every year approximately 3.3 million doges…

Read More

A General Overview of Diarrhea & Dehydration in Dairy & Beef Calves

October 3, 2017

By Andre Teixeira, DVM, PhD, Veterinary Affairs Director, Jaguar Health Part 1 in a 3-part series on diarrhea and dehydration in dairy & beef calves Diarrhea,…

Read More

  • 1
  • 2
  • 3
  • 4
  • 7

*Indication
MYTESI® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART).

Important Safety Information about MYTESI®
MYTESI® is not indicated for the treatment of infectious diarrhea. Rule out infectious etiologies of diarrhea before starting MYTESI®.

If infectious etiologies are not considered, there is a risk that patients with infectious etiologies will not receive the appropriate therapy and their disease may worsen. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (5.7%), bronchitis (3.9%), cough (3.5%), flatulence (3.1%), and increased bilirubin (3.1%).

Click to Read Full Prescribing Information